Life Sciences Patents Network Europe
The Bloomsbury Hotel, London-UK, 7th December 2016

Headline Sponsor
Our ambition at Allen & Overy is to help the world’s leading businesses maximise the opportunities that globalisation presents and meet the potential challenges. To support our clients’ international strategies, we have built a truly global network that covers Europe, Asia-Pacific, the Middle East, the Americas and Africa. 
As well as 44 offices in 31 countries we have developed strong ties with relationship law firms in over 100 countries where we do not have a presence. This network makes us one of the largest and most connected law firms in the world, with a global reach and local depth that is simply unrivalled. Global coverage in today’s market does not simply mean having offices in important cities around the world. For us, it means combining our international resources and sector expertise to work on cross-border transactions directly in the markets and regions important to our clients.


Osaka, Japan-based Abe & Partners works in a wide range of international and corporate matters with a focus on intellectual property law and international commerce. Patent litigation that Abe & Partners has participated in to date covers the fields of pharmaceuticals, chemistry, electronics and machinery, involving advanced technology such as biotechnology, semiconductors, etc, in cross-border matters. The firm has extensive experience in representing and advising multinational and domestic clients in the pharmaceutical industry and is currently involved in the battle between brand pharmaceutical companies and generic companies. 
Finnegan is one of the largest intellectual property law firms in the world. From offices in Atlanta, Boston, London, Palo Alto, Reston, Seoul, Shanghai, Taipei, Tokyo, and Washington, DC, the firm practises all aspects of patent, trademark, copyright, and trade secret law, including counselling, prosecution, licensing, and litigation. Finnegan also represents clients on IP issues related to European patents and trademarks, international trade, portfolio management, the internet, e-commerce, government contracts, antitrust, and unfair competition.
The fast pace of new discoveries and their commercial applications within the life sciences industry require a law firm that has a comprehensive grasp of the IP legal issues and the experience and industry nous to understand the scientific and strategic implications of the advancements. Finnegan delivers sophisticated legal strategies to help chemical, pharmaceutical, life sciences and biotech clients protect, advocate, and leverage their valuable IP assets. 
HGF is one of Europe’s largest firms of IP specialists and the second largest in the UK. The firm has offices in the UK and mainland Europe which offer an integrated IP solution with patent attorneys, trademark attorneys and IP solicitors to provide a full-service IP solution for clients. The firm is currently the second filer of Community trademarks and of Patent Cooperation Treaty applications.
HGF offers the full range of services expected from leading patent and trademark attorneys and solicitors, but it is our dynamic approach to oppositions and appeals, strategic portfolio development and acquisition due diligence that distinguishes HGF in the marketplace. HGF believes each client is unique and works hard to ensure we understand your objectives, timescales and budget to successfully achieve your goals. Our specialist teams have expertise and experience covering a range of technical fields including chemistry, engineering, electronics and life sciences.
Navigating complexities in the life sciences industry is no easy task. Successfully competing in the space requires a partner with a holistic, collaborative approach and a global perspective.
For life sciences innovators of all sizes, anywhere in the world, Hogan Lovells is that partner—from cutting-edge start-ups and boutique venture funds to world-renowned research institutions and health systems to global biopharmaceutical conglomerates.
Our team of 450 life sciences lawyers is located around the world but operates as if everyone is working from the same office, providing a seamless experience everywhere you do business.
No matter the challenge—from creation to commercialisation of a life-saving therapy, regulatory compliance to an international patent dispute, the formation of a strategic alliance to a complex, global merger—we’ve been there and we understand how to prepare you for what happens next, helping you to anticipate risks and address issues before they arise.
Mirandah Asia is an ASEAN-focused IP firm. Over 30 years, the Mirandah family name has grown to symbolise trust in Asian IP. From our offices in Singapore, Malaysia, Indonesia, Thailand, the Philippines and Vietnam, we link all 10 ASEAN countries, and India. 
Our founders—Patrick and Gladys Mirandah—are respected figures in Asian IP. Their organically handcrafted network blends traditional Asian values of dedication and patience, with modern international expectations of quality, professionalism and prompt service. 
We give back to our community. We have adopted 25 children from the Philippines, Indonesia, Vietnam, India, Cambodia and China. We sponsor a primary school in Delhi, India. We sing at old folks’ homes, plant trees and clean beaches in Singapore. We participate in typhoon relief aid in the Philippines.
Mirandah Asia simplifies challenging business environments. Our uniquely local perspective will give you the edge and peace of mind in South Asia.
WAN HUI DA - PEKSUNG Intellectual Property Group is the aggregates formed by the merger of WAN HUI DA Law Firm & IP Agency and PEKSUNG IP Ltd. in November 2016. Combining the strength of both firms, the new entity is a recognized leader in trademark services, a prominent solution provider in patent and technology services and a vigorous advocator of IP-related academic research. The combined firm houses over 400 IP professionals and a total of some 500 employees with presence in all major IP hubs in China. Benefiting from the merger, the clients will be served with an exceptional depth of sector expertise and the broadened offering of legal services covering the wide spectrum of trademark, patent, copyright and domain name prosecution and contentious, as well as litigation and disputes resolution pertaining to trade secret and technology-related matters.
RoyaltyStat is the most up-to-date and reliable online database of royalty rates extracted from unredacted licence agreements. RoyaltyStat’s rates are used to establish the royalty consideration, including upfront fees and milestone payments, for intellectual property. They are used in connection with IP valuation, litigation, business development, bankruptcy and mergers & acquisitions. In addition, we provide listed company financials from many countries, annual reports, and built-in tools to calculate comparable profit indicators and conduct what-if analyses. 
We provide online database access and economic consulting services. RoyaltyStat provides curated data and custom-built tools to determine arm’s length or reasonable royalty rates and profit indicators. With almost 17 years of online experience, RoyaltyStat’s reliable royalty rates extraction and normalisation help clients support IP and tax audits, business development planning, and contemporaneous documentation.
Venner Shipley is a medium size firm of European Patent and Trade Mark Attorneys and Lawyers, representing a broad range of clients including major domestic and international corporations, SMEs, universities and individual inventors in all sectors. Venner Shipley is well known for its expertise in relation to life sciences patents and transactions. Its legal team regularly advises clients on regulatory and funding questions and represents them in court, corporate transactions and regulatory matters.